# OnCo record farletuzumab-exatecan (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/farletuzumab-exatecan/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "farletuzumab-exatecan" ;
  schema:name "Farletuzumab-exatecan"@en ;
  schema:description "Farletuzumab-exatecan is an experimental antibody-drug conjugate from CSPC Megalith Biopharmaceutical in phase 2 trials, aimed at Folate receptor alpha."@en ;
  schema:url <https://onco.cc/drugs/farletuzumab-exatecan/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Farletuzumab-exatecan> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:targets <https://onco.cc/targets/folr1/> ;
  onco:companies <https://onco.cc/companies/cspc/> ;
  onco:trials <https://onco.cc/trials/nct07714668/>, <https://onco.cc/trials/nct07744763/> .